Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Perfusion Considerations 

Perfusion Considerations
Chapter:
Perfusion Considerations
Author(s):

Phillip Scott

and Jeffrey Riley

DOI:
10.1093/med/9780190909291.003.0025
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 26 May 2020

The effects of hemodilution during cardiopulmonary bypass (CPB) negatively impact a patient’s hemodynamic and coagulopathic states throughout all operative stages and into the postoperative care environment. Decisions by the surgical team to minimize fluid administration prove beneficial, and combining contemporary perfusion circuit prime reduction techniques, such as body mass index (BMI) correction, venous autologous priming (VAP), retrograde autologous priming (RAP), and antegrade prime displacement, greatly enables efforts of maintaining proper colloidal osmotic pressures (COP) while maximizing delivery of oxygen (DO2) during CPB. Adjuncts such as ultrafiltration (UF), use of vacuum assist venous drainage (VAVD), hyper-osmotic/oncotic solutions administration, and proportional volume replacement better prepare a patient for post-bypass management. Minimizing hemodilution tools facilitates transition onto mechanical circulatory support (MCS) devices such as extracorporeal membrane oxygenation (ECMO) and/or right or left ventricular assist device (RVAD/LVAD). Avoiding heparin rebound and dilutional coagulopathy in the intensive care unit further prevents additional blood product transfusions.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.